Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-surgical 4-Hydroxytamoxifen Gel vs Oral Tamoxifen in DCIS
NCT00952731Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of afimoxifene in ductal carcinoma in situ (DCIS) (2 arms), sponsored by Northwestern University. Primary endpoint: Difference Between Ki-67 Labeling Index in Tissue Samples Taken at Baseline and Post-treatment. Started Dec 2009; status: completed.
02
Drugs
afimoxifene
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT00952731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952731.